Managing The Mitral Valve In Hcm Surgery: Tips And Tricks
DOI:
https://doi.org/10.48729/pjctvs.574Keywords:
Hypertrophic Cardiomyopathy, systolic anterior motion, mitral regurgitation, septal myectomyAbstract
Mitral regurgitation (MR) in hypertrophic cardiomyopathy (HCM) patients is mainly due to systolic anterior motion (SAM) of the mitral valve (MV). However, other mechanisms contributing to mitral regurgitation may coexist as a result of further structural abnormalities. SAM might occur because of the increased septal thickness alone or due to simultaneous MV or subvalvular apparatus anomalies, such as mitral leaflet elongation, papillary muscle body anomalies, accessory papillary muscles or additional papillary muscle heads. Additionally, anomalous mitral chordae or the recently described mitral-aortic discontinuity (leading to a longer anterior mitral leaflet (AML)) can contribute to abnormal physiology. A closed aortomitral angle may also contribute. During intraoperative echocardiographic assessment, it is important to thoroughly evaluate the MV and the regurgitant jet to understand the mechanism(s) that cause MR in HCM patients. Although myectomy alone is frequently enough to correct SAM, concomitant MV procedures may be needed, especially when the septum is thin (<16-18 mm) and/or there is intrinsic MV disease. Detection of concomitant regurgitation mechanisms beyond SAM can eventually be identified preoperatively, either by direct structural detection (valve prolapse), by pharmacological palliation of SAM with vasopressors and negative inotropic agents or suspected by identification of anteriorly and centrally directed regurgitant mitral jets. Surgical techniques that can be employed to contribute to SAM elimination include plication/extension/retention plasty of the AML, resection/release/reorientation of papillary muscles, division of anomalous chordae, edge-to-edge repair, or, at times, prosthetic MV replacement. If there is structural MV disease concomitant to HCM, appropriately tailored techniques to address the MV may be used. Transoesophageal echocardiography at the end of the procedure should demonstrate elimination of SAM, resolution of LVOT obstruction, and appropriate coaptation of the MV leaflets and nearly resolution of MR. Provocation with inotropes can be used to ensure no latent obstruction persists.Downloads
References
Sherrid MV, Chaudhry FA, Swistel DG. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg. 2003;75(2):620-32. doi:10.1016/S0003-4975(02)04546-0
Lapenna E, Alfieri O, Nisi T, De Bonis M. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: the role of the edge-to-edge technique. J Card Surg. 2022;37(10):3336-41. doi:10.1111/jocs.15826
Ergi DG, Schaff HV, Ommen SR, Lahr BD, Lee A, et al. Changes in left ventricular-aortic angulation are associated with the development of obstruction in hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024. doi:10.1016/j.jtcs.2024.06.022
Hodges K, Rivas CG, Aguilera J, Borden R, Alashi A, et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. J Thorac Cardiovasc Surg. 2019;157(6):2289-99. doi:10.1016/j.tcs.2018.11.148
Hong JH, Schaff HV, Nishimura RA, Abel MD, Dearani JA, et al. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol. 2016;68(14):1497-1504. doi:10.1016/j.jacc.2016.07.735
Wei LM, Thibault DP, Rankin JS, Alkhouli M, Roberts HG, et al. Contemporary surgical management of hypertrophic cardiomyopathy in the United States. Ann Thorac Surg. 2019;107(2):460-6. doi:10.1016/j.athoracsur.2018.08.068
Wei LM, Thibault DP, Rankin JS, Alkhouli M, Roberts HG, et al. Contemporary surgical management of hypertrophic cardiomyopathy in the United States. Ann Thorac Surg. 2019;107(2):460-6. doi:10.1016/j.athoracsur.2018.08.068
Sherrid MV, Adams DH. The mitral valve in hypertrophic cardiomyopathy: other side of the outflow tract. J Am Coll Cardiol. 2020;76(19):2248-51. doi:10.1016/j.jacc.2020.09.580
Weissler-Snir A, Adler A, Rakowski H. MV surgery as adjunct to surgical myectomy for obstructive HCM: less is more than enough. J Am Coll Cardiol. 2016;68(14):1505-8. doi:10.1016/j.jacc.2016.04.070
Jain CC, Newman DB, Geske JB. Mitral valve disease in hypertrophic cardiomyopathy: evaluation and management. Curr Cardiol Rep. 2019;21(11):136. doi:10.1007/s11886-019-1231-8
Affronti A, Pruna-Guillen R, Sandoval E, Pereda D, Alcoer J, et al. Surgery for hypertrophic obstructive cardiomyopathy: comprehensive LVOT management beyond septal myectomy. J Clin Med. 2021;10(19):4397. doi:10.3390/cm10194397
Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context. J Am Coll Cardiol. 2016;67(15):1846-58. doi:10.1016/j.jacc.2016.01.071
Gharibeh I, Smedira NG, Grau JB. Comprehensive left ventricular outflow tract management beyond septal reduction to relieve obstruction. Asian Cardiovasc Thorac Ann. 2022;30(1):43-52. doi:10.1177/02184923211034689
Sakellaropoulos S, Svab S, Mohammed M, Dimitra L, Mitsis A. The role of the mitral valve in hypertrophic obstructive cardiomyopathy: an updated review. Curr Probl Cardiol. 2021;46(3):100641. doi:10.1016/j.cpcardiol.2020.100641
Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy: implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography. Circ Cardiovasc Imaging. 2015;8(7):e003132. doi:10.1161/circimaging.115.003132
Ferrazzi P, Spirito P, Lacovoni A, Calabrese A, Migliorati K, et al. Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy. J Am Coll Cardiol. 2015;66(15):1687-96. doi:10.1016/j.jacc.2015.07.069
Ferrazzi P, Spirito P, Binaco I, Zyrianov A, Poggio D, et al. Congenital muscular mitral-aortic discontinuity identified in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2020;76(19):2238-47. doi:10.1016/j.jacc.2020.09.534
Nampiaparampil RG, Swistel DG, Schlame M, Saric M, Sherrid MV. Intraoperative two- and three-dimensional transesophageal echocardiography in combined myectomy-mitral operations for hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2018;31(3):275-88. doi:10.1016/j.echo.2017.11.016
Maron MS, Rowin El, Maron BI. How to image hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2017;10(7):e005372. doi:10.1161/circimaging.116.005372
Swistel DG, Balaram SK. Surgical myectomy for hypertrophic cardiomyopathy in the 21st century: the evolution of the “RPR” repair—resection, plication, and release. Prog Cardiovasc Dis. 2012;54(6):498-502. doi:10.1016/j.pcad.2012.03.001
Kotkar KD, Said SM, Dearani JA, Schaff HV. Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience. Ann Cardiothorac Surg. 2017;6(4):329-36. doi:10.21037/acs.2017.07.03
Swistel DG, Massera D, Stepanovic A, Adlestein E, Reuter M, et al. Mitral leaflet shortening as an ancillary procedure in obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2024;118(2):440-8. doi:10.1016/j.athoracsur.2024.03.014
Said SM, Schaff HV. Surgical treatment of hypertrophic cardiomyopathy. Semin Thorac Cardiovasc Surg. 2013;25(4):300-9. doi:10.1053/j.semtos.2014.01.001
Ashikhmina EA, Schaff HV, Ommen SR, Dearani JA, Nishimura RA, et al. Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011;142(1):53-9. doi:10.1016/j.jtcs.2010.08.011
Downloads
Published
How to Cite
License
Copyright (c) 2025 Portuguese Journal of Cardiac Thoracic and Vascular Surgery

This work is licensed under a Creative Commons Attribution 4.0 International License.


